THERMO FISHER SCIENTIFIC INC (TMO) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:TMO • US8835561023

548.26 USD
+5.43 (+1%)
Last: Feb 9, 2026, 03:24 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to TMO. TMO was compared to 58 industry peers in the Life Sciences Tools & Services industry. TMO has a medium profitability rating, but doesn't score so well on its financial health evaluation. TMO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year TMO was profitable.
  • TMO had a positive operating cash flow in the past year.
  • In the past 5 years TMO has always been profitable.
  • TMO had a positive operating cash flow in each of the past 5 years.
TMO Yearly Net Income VS EBIT VS OCF VS FCFTMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • With an excellent Return On Assets value of 6.08%, TMO belongs to the best of the industry, outperforming 82.76% of the companies in the same industry.
  • TMO's Return On Equity of 12.55% is amongst the best of the industry. TMO outperforms 86.21% of its industry peers.
  • TMO has a better Return On Invested Capital (7.80%) than 79.31% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for TMO is significantly below the industry average of 13.34%.
Industry RankSector Rank
ROA 6.08%
ROE 12.55%
ROIC 7.8%
ROA(3y)6.22%
ROA(5y)6.79%
ROE(3y)12.72%
ROE(5y)14.58%
ROIC(3y)8.04%
ROIC(5y)9.02%
TMO Yearly ROA, ROE, ROICTMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • TMO's Profit Margin of 15.05% is amongst the best of the industry. TMO outperforms 84.48% of its industry peers.
  • TMO's Profit Margin has declined in the last couple of years.
  • TMO has a Operating Margin of 18.19%. This is amongst the best in the industry. TMO outperforms 82.76% of its industry peers.
  • TMO's Operating Margin has declined in the last couple of years.
  • TMO has a Gross Margin (41.22%) which is comparable to the rest of the industry.
  • TMO's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 18.19%
PM (TTM) 15.05%
GM 41.22%
OM growth 3Y-1.32%
OM growth 5Y-5.71%
PM growth 3Y-0.93%
PM growth 5Y-5.33%
GM growth 3Y-0.55%
GM growth 5Y-3.49%
TMO Yearly Profit, Operating, Gross MarginsTMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TMO is destroying value.
  • The number of shares outstanding for TMO has been reduced compared to 1 year ago.
  • TMO has less shares outstanding than it did 5 years ago.
  • TMO has a worse debt/assets ratio than last year.
TMO Yearly Shares OutstandingTMO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
TMO Yearly Total Debt VS Total AssetsTMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • TMO has a debt to FCF ratio of 6.26. This is a slightly negative value and a sign of low solvency as TMO would need 6.26 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.26, TMO is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
  • A Debt/Equity ratio of 0.67 indicates that TMO is somewhat dependend on debt financing.
  • TMO has a Debt to Equity ratio of 0.67. This is in the lower half of the industry: TMO underperforms 74.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 6.26
Altman-Z N/A
ROIC/WACC0.71
WACC11.05%
TMO Yearly LT Debt VS Equity VS FCFTMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • TMO has a Current Ratio of 1.89. This is a normal value and indicates that TMO is financially healthy and should not expect problems in meeting its short term obligations.
  • TMO has a worse Current ratio (1.89) than 62.07% of its industry peers.
  • TMO has a Quick Ratio of 1.53. This is a normal value and indicates that TMO is financially healthy and should not expect problems in meeting its short term obligations.
  • TMO has a Quick ratio of 1.53. This is in the lower half of the industry: TMO underperforms 60.34% of its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.53
TMO Yearly Current Assets VS Current LiabilitesTMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.62% over the past year.
  • The Earnings Per Share has been growing slightly by 3.19% on average over the past years.
  • Looking at the last year, TMO shows a small growth in Revenue. The Revenue has grown by 3.91% in the last year.
  • Measured over the past years, TMO shows a small growth in Revenue. The Revenue has been growing by 6.70% on average per year.
EPS 1Y (TTM)4.62%
EPS 3Y-0.53%
EPS 5Y3.19%
EPS Q2Q%7.7%
Revenue 1Y (TTM)3.91%
Revenue growth 3Y-0.27%
Revenue growth 5Y6.7%
Sales Q2Q%7.2%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.96% on average over the next years. This is quite good.
  • Based on estimates for the next years, TMO will show a small growth in Revenue. The Revenue will grow by 4.93% on average per year.
EPS Next Y8.54%
EPS Next 2Y9%
EPS Next 3Y9.51%
EPS Next 5Y10.96%
Revenue Next Year5.68%
Revenue Next 2Y5.47%
Revenue Next 3Y5.78%
Revenue Next 5Y4.93%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TMO Yearly Revenue VS EstimatesTMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
TMO Yearly EPS VS EstimatesTMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 23.97, which indicates a rather expensive current valuation of TMO.
  • Based on the Price/Earnings ratio, TMO is valued a bit cheaper than the industry average as 77.59% of the companies are valued more expensively.
  • TMO's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.93.
  • TMO is valuated rather expensively with a Price/Forward Earnings ratio of 22.09.
  • Based on the Price/Forward Earnings ratio, TMO is valued a bit cheaper than the industry average as 77.59% of the companies are valued more expensively.
  • TMO's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.77.
Industry RankSector Rank
PE 23.97
Fwd PE 22.09
TMO Price Earnings VS Forward Price EarningsTMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TMO is valued a bit cheaper than the industry average as 70.69% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, TMO is valued a bit cheaper than the industry average as 68.97% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 32.73
EV/EBITDA 21.4
TMO Per share dataTMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TMO does not grow enough to justify the current Price/Earnings ratio.
  • TMO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.81
PEG (5Y)7.52
EPS Next 2Y9%
EPS Next 3Y9.51%

6

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.32%, TMO is not a good candidate for dividend investing.
  • TMO's Dividend Yield is rather good when compared to the industry average which is at 0.09. TMO pays more dividend than 84.48% of the companies in the same industry.
  • With a Dividend Yield of 0.32, TMO pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

  • On average, the dividend of TMO grows each year by 14.69%, which is quite nice.
  • TMO has been paying a dividend for at least 10 years, so it has a reliable track record.
  • TMO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)14.69%
Div Incr Years7
Div Non Decr Years12
TMO Yearly Dividends per shareTMO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 9.49% of the earnings are spent on dividend by TMO. This is a low number and sustainable payout ratio.
  • TMO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.49%
EPS Next 2Y9%
EPS Next 3Y9.51%
TMO Yearly Income VS Free CF VS DividendTMO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
TMO Dividend Payout.TMO Dividend Payout, showing the Payout Ratio.TMO Dividend Payout.PayoutRetained Earnings

THERMO FISHER SCIENTIFIC INC

NYSE:TMO (2/9/2026, 3:24:09 PM)

548.26

+5.43 (+1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)04-21
Inst Owners92.78%
Inst Owner Change-2.48%
Ins Owners0.1%
Ins Owner Change4.84%
Market Cap205.99B
Revenue(TTM)44.56B
Net Income(TTM)6.70B
Analysts83.13
Price Target678.16 (23.69%)
Short Float %1.04%
Short Ratio1.95
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend1.68
Dividend Growth(5Y)14.69%
DP9.49%
Div Incr Years7
Div Non Decr Years12
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.64%
Min EPS beat(2)0.91%
Max EPS beat(2)4.37%
EPS beat(4)3
Avg EPS beat(4)1.7%
Min EPS beat(4)-0.07%
Max EPS beat(4)4.37%
EPS beat(8)6
Avg EPS beat(8)2.42%
EPS beat(12)7
Avg EPS beat(12)1.02%
EPS beat(16)11
Avg EPS beat(16)2.83%
Revenue beat(2)2
Avg Revenue beat(2)1.08%
Min Revenue beat(2)0.95%
Max Revenue beat(2)1.21%
Revenue beat(4)4
Avg Revenue beat(4)0.77%
Min Revenue beat(4)0.28%
Max Revenue beat(4)1.21%
Revenue beat(8)6
Avg Revenue beat(8)0.22%
Revenue beat(12)7
Avg Revenue beat(12)-0.27%
Revenue beat(16)11
Avg Revenue beat(16)1.95%
PT rev (1m)4.94%
PT rev (3m)8.59%
EPS NQ rev (1m)-5.63%
EPS NQ rev (3m)-5.81%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-0.4%
Revenue NQ rev (1m)-1.29%
Revenue NQ rev (3m)-1.22%
Revenue NY rev (1m)0.66%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE 23.97
Fwd PE 22.09
P/S 4.62
P/FCF 32.73
P/OCF 26.34
P/B 3.86
P/tB N/A
EV/EBITDA 21.4
EPS(TTM)22.87
EY4.17%
EPS(NY)24.82
Fwd EY4.53%
FCF(TTM)16.75
FCFY3.06%
OCF(TTM)20.81
OCFY3.8%
SpS118.59
BVpS142.17
TBVpS-31.37
PEG (NY)2.81
PEG (5Y)7.52
Graham Number270.48
Profitability
Industry RankSector Rank
ROA 6.08%
ROE 12.55%
ROCE 8.52%
ROIC 7.8%
ROICexc 8.73%
ROICexgc 37.4%
OM 18.19%
PM (TTM) 15.05%
GM 41.22%
FCFM 14.13%
ROA(3y)6.22%
ROA(5y)6.79%
ROE(3y)12.72%
ROE(5y)14.58%
ROIC(3y)8.04%
ROIC(5y)9.02%
ROICexc(3y)8.83%
ROICexc(5y)9.85%
ROICexgc(3y)40.31%
ROICexgc(5y)46.65%
ROCE(3y)8.78%
ROCE(5y)9.93%
ROICexgc growth 3Y-13.91%
ROICexgc growth 5Y-12.87%
ROICexc growth 3Y-6.93%
ROICexc growth 5Y-10.12%
OM growth 3Y-1.32%
OM growth 5Y-5.71%
PM growth 3Y-0.93%
PM growth 5Y-5.33%
GM growth 3Y-0.55%
GM growth 5Y-3.49%
F-Score5
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 6.26
Debt/EBITDA 3.29
Cap/Depr 54.86%
Cap/Sales 3.42%
Interest Coverage 250
Cash Conversion 71.83%
Profit Quality 93.88%
Current Ratio 1.89
Quick Ratio 1.53
Altman-Z N/A
F-Score5
WACC11.05%
ROIC/WACC0.71
Cap/Depr(3y)47.77%
Cap/Depr(5y)61.4%
Cap/Sales(3y)3.38%
Cap/Sales(5y)4.31%
Profit Quality(3y)108.05%
Profit Quality(5y)102.29%
High Growth Momentum
Growth
EPS 1Y (TTM)4.62%
EPS 3Y-0.53%
EPS 5Y3.19%
EPS Q2Q%7.7%
EPS Next Y8.54%
EPS Next 2Y9%
EPS Next 3Y9.51%
EPS Next 5Y10.96%
Revenue 1Y (TTM)3.91%
Revenue growth 3Y-0.27%
Revenue growth 5Y6.7%
Sales Q2Q%7.2%
Revenue Next Year5.68%
Revenue Next 2Y5.47%
Revenue Next 3Y5.78%
Revenue Next 5Y4.93%
EBIT growth 1Y5.05%
EBIT growth 3Y-1.59%
EBIT growth 5Y0.61%
EBIT Next Year19.29%
EBIT Next 3Y11.41%
EBIT Next 5Y10.61%
FCF growth 1Y-13.39%
FCF growth 3Y-3.07%
FCF growth 5Y-1.58%
OCF growth 1Y-9.78%
OCF growth 3Y-5.12%
OCF growth 5Y-1.16%

THERMO FISHER SCIENTIFIC INC / TMO FAQ

What is the ChartMill fundamental rating of THERMO FISHER SCIENTIFIC INC (TMO) stock?

ChartMill assigns a fundamental rating of 4 / 10 to TMO.


What is the valuation status of THERMO FISHER SCIENTIFIC INC (TMO) stock?

ChartMill assigns a valuation rating of 4 / 10 to THERMO FISHER SCIENTIFIC INC (TMO). This can be considered as Fairly Valued.


What is the profitability of TMO stock?

THERMO FISHER SCIENTIFIC INC (TMO) has a profitability rating of 6 / 10.


What is the financial health of THERMO FISHER SCIENTIFIC INC (TMO) stock?

The financial health rating of THERMO FISHER SCIENTIFIC INC (TMO) is 3 / 10.


What is the expected EPS growth for THERMO FISHER SCIENTIFIC INC (TMO) stock?

The Earnings per Share (EPS) of THERMO FISHER SCIENTIFIC INC (TMO) is expected to grow by 8.54% in the next year.